These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 31292927)

  • 21. Nipple Sparing Mastectomy as a Risk-Reducing Procedure for BRCA-Mutated Patients.
    Rocco N; Montagna G; Criscitiello C; Nava MB; Privitera F; Taher W; Gloria A; Catanuto G
    Genes (Basel); 2021 Feb; 12(2):. PubMed ID: 33578759
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of family history on choosing risk-reducing surgery among BRCA mutation carriers.
    Singh K; Lester J; Karlan B; Bresee C; Geva T; Gordon O
    Am J Obstet Gynecol; 2013 Apr; 208(4):329.e1-6. PubMed ID: 23333547
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surgical and financial implications of genetic counseling and requests for concurrent prophylactic mastectomy.
    Murphy RX; Adkinson JM; Namey T; Eid S; Bleznak A
    Ann Plast Surg; 2010 May; 64(5):684-7. PubMed ID: 20395792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Less correspondence between expectations before and cosmetic results after risk-reducing mastectomy in women who are mutation carriers: a prospective study.
    Brandberg Y; Arver B; Johansson H; Wickman M; Sandelin K; Liljegren A
    Eur J Surg Oncol; 2012 Jan; 38(1):38-43. PubMed ID: 22032910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nipple-sparing mastectomy in BRCA1/2 mutation carriers: an interim analysis and review of the literature.
    Yao K; Liederbach E; Tang R; Lei L; Czechura T; Sisco M; Howard M; Hulick PJ; Weissman S; Winchester DJ; Coopey SB; Smith BL
    Ann Surg Oncol; 2015 Feb; 22(2):370-6. PubMed ID: 25023546
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Feasibility study of contralateral risk-reducing mastectomy with breast reconstruction for breast cancer patients with BRCA mutations in Japan.
    Yoshimura A; Okumura S; Sawaki M; Hattori M; Ishiguro J; Adachi Y; Kotani H; Gondo N; Kataoka A; Iwase M; Onishi S; Sugino K; Terada M; Horisawa N; Mori M; Takaiso N; Hyodo I; Iwata H
    Breast Cancer; 2018 Sep; 25(5):539-546. PubMed ID: 29520501
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical experience of prophylactic mastectomy followed by immediate breast reconstruction in women at hereditary risk of breast cancer (HB(O)C) or a proven BRCA1 and BRCA2 germ-line mutation.
    Contant CM; Menke-Pluijmers MB; Seynaeve C; Meijers-Heijboer EJ; Klijn JG; Verhoog LC; Tjong Joe Wai R; Eggermont AM; van Geel AN
    Eur J Surg Oncol; 2002 Sep; 28(6):627-32. PubMed ID: 12359199
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patient experience with breast reconstruction process following bilateral mastectomy in BRCA mutation carriers.
    Nurudeen S; Guo H; Chun Y; Coopey S; Barry W; Garber J; Dominici LS
    Am J Surg; 2017 Oct; 214(4):687-694. PubMed ID: 28683895
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of Mammographic Measurements to Predict Complications After Nipple-Sparing Mastectomy in BRCA Mutation Carriers.
    Park KU; Weiss A; Rosso K; Yi M; Hunt K; Kuerer H; Hanson SE; Candelaria R; Tevis S; Thompson A
    Ann Surg Oncol; 2020 Feb; 27(2):367-372. PubMed ID: 31399819
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differences among a Portuguese cohort of BRCA pathogenic/likely pathogenic variants carriers choosing risk-reducing mastectomy or intensive breast surveillance.
    Torres S; Peleteiro B; Magalhães A; Garrido L; Costa S; Fougo JL
    J Cancer Res Clin Oncol; 2023 Aug; 149(10):7529-7538. PubMed ID: 36971799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current knowledge of risk reducing mastectomy: Indications, techniques, results, benefits, harms.
    Baildam AD
    Breast; 2019 Aug; 46():48-51. PubMed ID: 31082761
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The frequency and outcome of breast cancer risk-reducing surgery in Finnish BRCA1 and BRCA2 mutation carriers.
    Koskenvuo L; Svarvar C; Suominen S; Aittomäki K; Jahkola T
    Scand J Surg; 2014 Mar; 103(1):34-40. PubMed ID: 24177987
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complications, risk factors, and patients-reported outcomes after skin-sparing mastectomy followed by breast reconstruction in women with BRCA mutations.
    Moberg IO; Schou Bredal I; Schneider MR; Tønseth KA; Schlichting E
    J Plast Surg Hand Surg; 2018 Aug; 52(4):234-239. PubMed ID: 29741462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Initial experience with surgical treatment planning in the newly diagnosed breast cancer patient at high risk for BRCA-1 or BRCA-2 mutation.
    Stolier AJ; Fuhrman GM; Mauterer L; Bolton JS; Superneau DW
    Breast J; 2004; 10(6):475-80. PubMed ID: 15569201
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-effectiveness of surveillance and prevention strategies in BRCA1/2 mutation carriers.
    Yamauchi H; Nakagawa C; Kobayashi M; Kobayashi Y; Mano T; Nakamura S; Arai M
    Breast Cancer; 2018 Mar; 25(2):141-150. PubMed ID: 29019095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patient Satisfaction and Nipple-Areola Sensitivity After Bilateral Prophylactic Mastectomy and Immediate Implant Breast Reconstruction in a High Breast Cancer Risk Population: Nipple-Sparing Mastectomy Versus Skin-Sparing Mastectomy.
    van Verschuer VM; Mureau MA; Gopie JP; Vos EL; Verhoef C; Menke-Pluijmers MB; Koppert LB
    Ann Plast Surg; 2016 Aug; 77(2):145-52. PubMed ID: 26076217
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Residual glandular tissue (RGT) in BRCA1/2 germline mutation carriers with unilateral and bilateral prophylactic mastectomies.
    Grinstein O; Krug B; Hellmic M; Siedek F; Malter W; Burke C; Schmutzler R; Maintz D; Rhiem K
    Surg Oncol; 2019 Jun; 29():126-133. PubMed ID: 31196476
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prophylactic and therapeutic mastectomy in BRCA mutation carriers: can the nipple be preserved?
    Reynolds C; Davidson JA; Lindor NM; Glazebrook KN; Jakub JW; Degnim AC; Sandhu NP; Walsh MF; Hartmann LC; Boughey JC
    Ann Surg Oncol; 2011 Oct; 18(11):3102-9. PubMed ID: 21947588
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Breast cancer after bilateral risk-reducing mastectomy.
    Skytte AB; Crüger D; Gerster M; Laenkholm AV; Lang C; Brøndum-Nielsen K; Andersen MK; Sunde L; Kølvraa S; Gerdes AM
    Clin Genet; 2011 May; 79(5):431-7. PubMed ID: 21199491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reasons for risk-reducing mastectomy versus MRI-screening in a cohort of women at high hereditary risk of breast cancer.
    Haroun I; Graham T; Poll A; Sun P; Hill K; Weitzner E; Narod S; Warner E
    Breast; 2011 Jun; 20(3):254-8. PubMed ID: 21306899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.